Publicaciones

Type

By researcher

By affiliation

Title Issue Date
Prostate cancer and the androgen receptor gene Bosch, Domingo Navarro ; Galván, Juan J.Cabrera; Ponce, Nicolás Chesa; Díaz-Chico, B. Nicolás Issued date: 2002 DOI: 10.1007/BF02732507 Source: Clinical and Translational Oncology [ISSN 1699-048X], v. 4, p. 228-240 SCIE Artículo
Rho GTPases in human carcinogenesis: A tale of excess Benitah, Salvador Aznar; Espina, Carolina; Valerón, Pilar F. ; Lacal, Juan Carlos Issued date: 2003 DOI: 10.1007/BF02728199 Source: Clinical and Translational Oncology [ISSN 1699-048X, eISSN 1699-3055], v. 5, p. 70-78, (2003) SCIE Artículo
Erythropoietin in cancer treatment: Considerations about Henke's article Biete Sola, Alberto; Calvo Manuel, Felipe A.; Clavo Varas, Bernardino ; Fernández Pérez, Cristina; Porto Vázquez, Carmen, et al Issued date: 2005 DOI: 10.1007/BF02716548 Source: Clinical and Translational Oncology[ISSN 1699-048X],v. 7, p. 332-335 SCIE Actas de congresos
An interview with Nicolás Díaz Chico, president of the Spanish Association for Cancer Research (ASEICA) Díaz Chico, Nicolás; García Jordá, Enrique Issued date: 2008 DOI: 10.1007/s12094-008-0192-y Source: Clinical and Translational Oncology [ISSN 1699-048X], v. 10 (5), p. 248-249, (Diciembre 2008) SCIE Artículo
Molecular biomarkers in the decision of treatment of cervical carcinoma patients Valenciano, A.; Henríquez-Hernández, L. A. ; Lloret, M.; Pinar, B.; Lara, P. C. Issued date: 2013 DOI: 10.1007/s12094-013-1018-0 Source: Clinical and Translational Oncology[ISSN 1699-048X],v. 15, p. 587-592 JCR: 1,6 - Q4 SCIE Artículo
New biological markers in the decision of treatment of head and neck cancer patients Valenciano, A.; Henríquez-Hernández, L. A. ; Lloret, M.; Pinar, B.; Lara, P. C. Issued date: 2014 DOI: 10.1007/s12094-014-1193-7 Source: Clinical and Translational Oncology[ISSN 1699-048X],v. 16, p. 849-858 JCR: 2,077 - Q3 SCIE Reseña
Demand for radiotherapy in Spain Borrás, J. M.; López-Torrecilla, J.; Algara, M.; Palacios-Eito, A.; Gómez-Caamaño, A., et al Issued date: 2017 DOI: 10.1007/s12094-016-1525-x Source: Clinical and Translational Oncology [ISSN 1699-048X], v. 19 (2), p. 204-210 JCR: 2,392 - Q3 SCIE Reseña
Predictive value of hypoxia in advanced head and neck cancer after treatment with hyperfractionated radio-chemotherapy and hypoxia modification Clavo, B. ; Robaina, F.; Fiuza, D.; Ruiz, A.; Lloret, M., et al Issued date: 2017 DOI: 10.1007/s12094-016-1541-x Source: Clinical and Translational Oncology[ISSN 1699-048X],v. 19, p. 419-424 JCR: 2,392 - Q3 SCIE Artículo
Infrastructure and equipment for radiation oncology in the Spanish National Health System: analysis of external beam radiotherapy 2015-2020 Rodríguez, Ana; Algara, M.; Monge, D.; López-Torrecilla, J.; Caballero, F., et al Issued date: 2018 DOI: 10.1007/s12094-017-1727-x Source: Clinical & Translational Oncology [ISSN 1699-048X], v. 20 (3), p. 402-410 SJR: 0,883 - Q1 JCR: 2,441 - Q3 SCIE Artículo
Quality indicators in radiation oncology: proposal of the Spanish Society of Radiation Oncology (SEOR) for a continuous improvement of the quality of care in oncology López Torrecilla, J.; Marín i Borràs, S.; Ruiz-Alonso, A.; Jaen Olasolo, J.; Vázquez de la Torre, M. L., et al Issued date: 2019 DOI: 10.1007/s12094-018-1943-z Source: Clinical and Translational Oncology [ISSN 1699-048X], v. 21 (4), p. 519-533 SJR: 0,833 - Q2 JCR: 2,737 - Q3 SCIE Artículo
Hypofractionation vs. conventional radiotherapy fractionation in the conservative treatment of T1 glottic cancer: a prospective cohort study Salas-Salas, B. G.; Domínguez-Nuez, D. J.; Cabrera, R.; Ferrera-Alayón, L.; Lloret Sáez-Bravo, Marta , et al Issued date: 2019 DOI: 10.1007/s12094-019-02118-7 Source: Clinical and Translational Oncology [ISSN 1699-048X], v. 22, p. 151–157 SJR: 0,833 - Q2 JCR: 2,737 - Q3 SCIE Artículo
Feasibility of a deep hyperthermia and radiotherapy programme for advanced tumors: first Spanish experience Lloret Sáez-Bravo, Marta ; García-Cabrera, L.; Hernandez, A.; Santana, N.; López-Molina, L., et al Issued date: 2019 DOI: 10.1007/s12094-019-02097-9 Source: Clinical and Translational Oncology [ISSN 1699-048X], v. 21 (12), p. 1771-1775 SJR: 0,833 - Q2 JCR: 2,737 - Q3 SCIE Artículo
A strategic reflection for the management and implementation of CAR-T therapy in Spain: an expert consensus paper Zozaya González, Mª Neboa ; Villaseca, J.; Abdalla, F.; Calleja, M. A.; Díez-Martín, J. L., et al Issued date: 2022 DOI: 10.1007/s12094-021-02757-9 Source: Clinical and Translational Oncology[ISSN 1699-048X], v. 24, p. 968-980 SJR: 0,831 - Q2 JCR: 3,4 - Q3 SCIE MIAR ICDS: 10,8 Artículo
An effective algorithm to detect the possibility of being MSI phenotype in endometrial cancer given the BMI status and histological subtype: a statistical study González Villa, Isabel ; González Dávila, Enrique Francisco; Expósito Afonso, Idaira Jael ; Martínez Blanco, Leynis Isabel; Loro Ferrer, Juan Francisco , et al Issued date: 2022 DOI: 10.1007/s12094-022-02837-4 Source: Clinical and Translational Oncology[ISSN 1699-048X], (Mayo 2022) SJR: 0,831 - Q2 JCR: 3,4 - Q3 SCIE MIAR ICDS: 10,8 Artículo preliminar
Identification of non-actionable mutations with prognostic and predictive value in patients with advanced or metastatic non-small cell lung cancer Provencio Pulla, Mariano; Pérez Parente, Diego; Olson, Sara; Ruiz Gracia, Pedro; Vilas, Esther, et al Issued date: 2024 DOI: 10.1007/s12094-023-03362-8 Source: Clinical & translational oncology [ISSN 1699-048X], v. 26 (6), p. 1384-1394, (2024). SJR: 0,837 - Q2 JCR: 3,4 - Q3 SCIE MIAR ICDS: 10,8 Artículo
The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy Gómez Rueda, Ana; Taus, Álvaro; Álvarez Álvarez, Rosa; Bernabé-Caro, Reyes; Chara, Luis, et al Issued date: 2024 DOI: 10.1007/s12094-024-03404-9 Source: Clinical & translational oncology [ISSN 1699-048X], v. 26 (7), p. 1779-1789, (2024). SJR: 0,837 - Q2 JCR: 3,4 - Q3 SCIE MIAR ICDS: 10,8 Artículo